Catching Cancer Early: How An Indian Startup Pulled Off Remarkable Breakthrough swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
Read more about Biotech cos Tzar Labs and Epigeneres to launch early-detection cancer tests on Business Standard. Firms claim breakthrough with their RNA-marker tech which detects cancer even in stage zero
Five Indian Startups Taking On Cancer To help the healthcare industry and simultaneously bring life-changing innovation, several Indian startups are working to return the hope that was once lost among cancer patients
Stay informed and join our daily newsletter now!
Email
You re reading Entrepreneur India, an international franchise of Entrepreneur Media.
The World Health Organization (WHO) in a report said India witnessed close to 1.16 million new cancer cases and 784,800 cancer deaths in 2018. In India, where the healthcare infrastructure is yet to catch up with its western counterpart and is collapsing at a much faster rate
if a person is diagnosed with cancer, their hope to survive is crushed instantaneously. To help the healthcare industry and simultaneously bring life-changing innovation to the table, several Indian startups are working with all their strength to return the hope that was once lost among cancer patients
A Ground-Breaking India-Led Cancer Test is Set to Launch This Year
The family has agreed to call the treatment HrC after Dr. Tripathi s son-in-law and former high-profile Mumbai police officer Himanshu Roy died by suicide in 2018 while battling cancer.
| 10 May 2021 11:50 AM GMT
New Delhi- An Indian biotechnology project claims to have made a significant breakthrough in cancer early detection that, if approved by regulators by the end of the year, could significantly advance cancer diagnosis and save millions of lives.
Epigeneres Biotechnology in Mumbai and Tzar Labs in Singapore, both led by nanotech scientist Vinay Kumar Tripathi and his family, have published their findings in a peer-reviewed journal based in Berlin, claiming 100 percent efficacy.
Indian-Led Ground-Breaking Cancer Test Hopes To Launch This Year Indian-Led Ground-Breaking Cancer Test Hopes To Launch This Year Marked by a simple blood test followed by molecular analysis, Mumbai-based Epigeneres Biotechnology and Singapore-based Tzar Labs have named the test HrC.
Epigeneres Biotechnology and Tzar Labs have developed the test. (Representational)
New Delhi:
An Indian biotechnology initiative has claimed a striking breakthrough in the early detection of cancer that could dramatically advance the diagnosis of the disease, saving millions of lives, once cleared by regulators as early as the end of this year.
Mumbai-based Epigeneres Biotechnology and Singapore-based Tzar Labs, both led by nanotech scientist Vinay Kumar Tripathi and his family, have published their findings claiming 100 per cent efficacy in a peer-reviewed reviewed journal out of Berlin.